Dr. Reddy's Laboratories Ltd Common Stock vs SoundHound AI Inc — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B), while SoundHound AI Inc trades at $4.43 (market cap $2.01B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 5.3× SoundHound AI Inc's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while SoundHound AI Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and SoundHound AI Inc for 24 Days on average.
| RDY | SOUN | |
|---|---|---|
Market Cap | $10.61B | $2.01B |
Volume | 3,738,869 | 19,541,649 |
Sector | Health | Technology |
52-Week High | $15.38 | $21.40 |
52-Week Low | $11.38 | $4.53 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $10.51B | $1.81B |
Dividend Yield | 0.65% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SoundHound AI (SOUN) trades at $4.88, down 1.81% on the day, with a bearish technical signal despite bullish oscillators. The company shows strong revenue growth ($169M in 2025, $203M projected for 2026) but deep losses (-$14M net income in 2025). Recent developments include expansion in restaurant and banking sectors with its OASYS Edge technology. Analyst consensus is strongly bullish with a $9.33 price target, representing 91% upside potential from current levels.
While facing significant profitability challenges and negative cash flow trends, SOUN's expanding market footprint and consistent earnings beats create potential for long-term growth. Key risks include integration challenges from acquisitions, high valuation multiples, and ongoing cash burn. The stock offers substantial upside if execution improves but requires careful risk management given current financial metrics.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →